Chengrong Lu

1.2k total citations
25 papers, 967 citations indexed

About

Chengrong Lu is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Chengrong Lu has authored 25 papers receiving a total of 967 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Immunology and 6 papers in Oncology. Recurrent topics in Chengrong Lu's work include Cancer-related Molecular Pathways (5 papers), MicroRNA in disease regulation (4 papers) and RNA modifications and cancer (3 papers). Chengrong Lu is often cited by papers focused on Cancer-related Molecular Pathways (5 papers), MicroRNA in disease regulation (4 papers) and RNA modifications and cancer (3 papers). Chengrong Lu collaborates with scholars based in China, United States and Japan. Chengrong Lu's co-authors include Feng Zhu, Zigang Dong, Ann M. Bode, Faqing Tang, Yong‐Yeon Cho, Tatyana A. Zykova, Weiya Ma, Chengshan Xu, Yuan Luo and Fuchu He and has published in prestigious journals such as Journal of Biological Chemistry, Molecular Cell and Cancer Research.

In The Last Decade

Chengrong Lu

25 papers receiving 956 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chengrong Lu China 17 629 202 174 103 84 25 967
Salvador Naranjo‐Suarez Spain 15 539 0.9× 140 0.7× 271 1.6× 71 0.7× 110 1.3× 22 917
María Jesús Pujol Spain 18 736 1.2× 242 1.2× 112 0.6× 100 1.0× 59 0.7× 32 943
Nathan Lanning United States 16 530 0.8× 178 0.9× 238 1.4× 52 0.5× 46 0.5× 19 872
Lida Guo United States 17 558 0.9× 134 0.7× 105 0.6× 232 2.3× 83 1.0× 23 1.1k
Anja Krones‐Herzig Germany 17 657 1.0× 204 1.0× 230 1.3× 61 0.6× 143 1.7× 19 1.1k
Kai Jiang China 19 716 1.1× 146 0.7× 326 1.9× 54 0.5× 112 1.3× 37 1.1k
Ajay K. Yadav India 15 587 0.9× 173 0.9× 281 1.6× 43 0.4× 114 1.4× 40 968
Seung‐Hee Jo United States 12 568 0.9× 177 0.9× 201 1.2× 71 0.7× 90 1.1× 16 964
Takamasa Kanbe Japan 11 484 0.8× 114 0.6× 121 0.7× 67 0.7× 133 1.6× 17 845

Countries citing papers authored by Chengrong Lu

Since Specialization
Citations

This map shows the geographic impact of Chengrong Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengrong Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengrong Lu more than expected).

Fields of papers citing papers by Chengrong Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengrong Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengrong Lu. The network helps show where Chengrong Lu may publish in the future.

Co-authorship network of co-authors of Chengrong Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Chengrong Lu. A scholar is included among the top collaborators of Chengrong Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengrong Lu. Chengrong Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Xiaoyi, Lihong Fan, Chengrong Lu, Shutao Yin, & Hongbo Hu. (2020). Functional Role of p53 in the Regulation of Chemical-Induced Oxidative Stress. Oxidative Medicine and Cellular Longevity. 2020. 1–10. 52 indexed citations
2.
Luo, Yuan, Xinyu Wen, Ling Wang, et al.. (2016). Identification of MicroRNAs Involved in Growth Arrest and Apoptosis in Hydrogen Peroxide‐Treated Human Hepatocellular Carcinoma Cell Line HepG2. Oxidative Medicine and Cellular Longevity. 2016(1). 7530853–7530853. 13 indexed citations
3.
Xu, Chengshan, et al.. (2016). MicroRNA-3196 is inhibited by H2AX phosphorylation and attenuates lung cancer cell apoptosis by downregulating PUMA. Oncotarget. 7(47). 77764–77776. 18 indexed citations
4.
Lu, Jinping, Damao Huang, Yuejin Li, et al.. (2016). Cdk3-promoted epithelial-mesenchymal transition through activating AP-1 is involved in colorectal cancer metastasis. Oncotarget. 7(6). 7012–7028. 29 indexed citations
5.
Xiong, Min, et al.. (2015). Resveratrol induces apoptosis of human chronic myelogenous leukemia cells in vitro through p38 and JNK-regulated H2AX phosphorylation. Acta Pharmacologica Sinica. 36(3). 353–361. 51 indexed citations
6.
Xu, Chengshan, et al.. (2015). MicroRNA-1915-3p prevents the apoptosis of lung cancer cells by downregulating DRG2 and PBX2. Molecular Medicine Reports. 13(1). 505–512. 11 indexed citations
7.
Dong, Yaqiong, Min Xiong, Ze Liu, et al.. (2014). H2AX phosphorylation regulated by p38 is involved in Bim expression and apoptosis in chronic myelogenous leukemia cells induced by imatinib. APOPTOSIS. 19(8). 1281–1292. 29 indexed citations
8.
Lu, Chengrong, Min Xiong, Yuan Luo, et al.. (2013). Genome-wide transcriptional analysis of apoptosis-related genes and pathways regulated by H2AX in lung cancer A549 cells. APOPTOSIS. 18(9). 1039–1047. 25 indexed citations
9.
Zhang, Yanjun, Chengrong Lu, Yan Cao, et al.. (2012). Imatinib induces H2AX phosphorylation and apoptosis in chronic myelogenous leukemia cells in vitro via caspase-3/Mst1 pathway. Acta Pharmacologica Sinica. 33(4). 551–557. 41 indexed citations
10.
Luo, Yuan, et al.. (2011). [Expression of NKG2D and NKG2A with their ligands MHC-I A/B and HLA-E in acute leukemia patients and its significance].. PubMed. 19(2). 312–6. 3 indexed citations
11.
Cho, Yong‐Yeon, Faqing Tang, Ke Yao, et al.. (2008). Cyclin-Dependent Kinase-3–Mediated c-Jun Phosphorylation at Ser63 and Ser73 Enhances Cell Transformation. Cancer Research. 69(1). 272–281. 54 indexed citations
12.
Zykova, Tatyana A., Feng Zhu, Chengrong Lu, et al.. (2008). TOPK phosphorylation of histone H2AX prevents arsenite-induced apoptosis in RPMI7951 melanoma cells. Cancer Research. 68. 2707–2707. 1 indexed citations
13.
Lu, Chengrong, Ying Shi, Zhe Wang, et al.. (2008). Serum starvation induces H2AX phosphorylation to regulate apoptosis via p38 MAPK pathway. FEBS Letters. 582(18). 2703–2708. 71 indexed citations
14.
Lu, Chengrong, Feng Zhu, Yong‐Yeon Cho, et al.. (2006). Cell Apoptosis: Requirement of H2AX in DNA Ladder Formation, but Not for the Activation of Caspase-3. Molecular Cell. 23(1). 121–132. 301 indexed citations
15.
Zhao, Qing, Zhiwei He, Nanyue Chen, et al.. (2005). 2-Arachidonoylglycerol Stimulates Activator Protein-1-dependent Transcriptional Activity and Enhances Epidermal Growth Factor-induced Cell Transformation in JB6 P+ Cells. Journal of Biological Chemistry. 280(29). 26735–26742. 22 indexed citations
16.
Wang, Yan, Chengrong Lu, Handong Wei, et al.. (2004). Hepatopoietin interacts directly with COP9 signalosome and regulates AP‐1 activity. FEBS Letters. 572(1-3). 85–91. 22 indexed citations
17.
Li, Yingxian, Chengrong Lu, Guichun Xing, Yunping Zhu, & Fuchu He. (2004). Macrophage migration inhibitory factor directly interacts with hepatopoietin and regulates the proliferation of hepatoma cell. Experimental Cell Research. 300(2). 379–387. 27 indexed citations
18.
Li, Yong, Kaihua Wei, Chengrong Lu, et al.. (2002). Identification of hepatopoietin dimerization, its interacting regions and alternative splicing of its transcription. European Journal of Biochemistry. 269(16). 3888–3893. 27 indexed citations
19.
Lu, Chengrong, Yong Li, Yanlin Zhao, et al.. (2001). Intracrine hepatopoietin potentiates AP‐1 activity through JAB1 independent of MAPK pathway. The FASEB Journal. 16(1). 1–18. 62 indexed citations
20.
Lu, Chengrong, et al.. (1989). A 3 MV Pelletron at Fudan University. Nuclear Instruments and Methods in Physics Research Section B Beam Interactions with Materials and Atoms. 40-41. 714–717. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Salvador Naranjo‐Suarez Breakdown of academic impact, for papers by María Jesús Pujol Breakdown of academic impact, for papers by Nathan Lanning Breakdown of academic impact, for papers by Lida Guo Breakdown of academic impact, for papers by Anja Krones‐Herzig Breakdown of academic impact, for papers by Kai Jiang Breakdown of academic impact, for papers by Ajay K. Yadav Breakdown of academic impact, for papers by Seung‐Hee Jo Breakdown of academic impact, for papers by Takamasa Kanbe
Rankless by CCL
2026